What it may be used for
It is not approved as a general erectile-dysfunction enhancer for men. Compounded combinations may represent off-label/unapproved use.
Bremelanotide compounded formulation
Prescription treatment is never guaranteed. A licensed clinician decides what is appropriate; a pharmacy confirms formulation and availability.
Bremelanotide is a melanocortin receptor agonist. An FDA-approved product has a specific indication for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.
It is not approved as a general erectile-dysfunction enhancer for men. Compounded combinations may represent off-label/unapproved use.
Approved-product limits on timing and frequency do not automatically translate to compounded combinations. Follow the prescriber and pharmacy label.
Nausea, flushing, headache and injection-site reactions can occur; transient blood-pressure increases and heart-rate decreases are important considerations.
Food is not a substitute for cardiovascular screening or product-specific instructions.
Discuss uncontrolled hypertension, cardiovascular disease, pregnancy and medicines whose absorption could be affected by slowed gastric emptying.
Compounded formulations are not FDA-approved as finished products. Availability and legal status vary by jurisdiction and patient-specific need.
These are formulations/strengths found in the supplied pharmacy-partner catalog. They are shown for transparency and are not a dosing recommendation. Country, prescription, clinical appropriateness and pharmacy availability determine what can actually be dispensed.
That answer belongs on your prescription label, not on a marketing page. Doses can change with the indication, formulation, concentration, other medicines, kidney/liver function and your clinician’s plan. eHealthMedic is designed to send your assessment to the correct licensed provider for your country, then route an authorized prescription to the configured pharmacy partner.
Tell us where you live and answer a private health assessment. Your request will be routed to the appropriate country-specific clinical provider once that integration is connected.